COvid-19 REgistry on THROMBOSIS Complications Associated With Hospitalization
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 2,708
- 试验地点
- 30
- 主要终点
- All-cause death
研究概览
简要总结
This online-based, observational retrospective registry aims to (i) study the rate of cardiovascular events, encompassing venous thromboembolic and arterial events, in consecutive hospitalized patients with coronavirus (Covid19), (ii) investigate the prevalent use of thromboprophylaxis, (iii) describe the use of imaging tests for the detection of cardiovascular events in patients with Covid19. This will also facilitate and constitute the basis for the conduction of interventional thromboprophylaxis studies in patients with Covid19.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Hospitalized patients aged ≥ 18 years with a positive test for severe acute respiratory syndrome corona virus 2 (SARS-CoV2)
排除标准
- 未提供
结局指标
主要结局
All-cause death
时间窗: during index hospitalization for Covid19
Rate of death from any cause
Fatal or non-fatal venous thromboembolism (VTE)
时间窗: during index hospitalization for Covid19
Rate of thromboembolic events encompassing pulmonary embolism (PE) and deep vein thrombosis (DVT)
Fatal or non-fatal cardiovascular events
时间窗: during index hospitalization for Covid19
Rate of cardiovascular events encompassing stroke and myocardial infarction
次要结局
- Length of hospitalization(first index hospitalization for Covid19)
- Prevalence of cardiovascular risk factors(at baseline/enrollment)
- In-hospital course of D-dimer (μg/mL)(during index hospitalization for Covid19)
- In-hospital course of Troponin (ng/ml)(during index hospitalization for Covid19)
- Prevalent use of in-hospital thromboprophylaxis(during index hospitalization for Covid19)
研究者
Prof. Stavros Konstantinides, MD
Prof Stavros Konstantinides, MD, Medical Director of the
Johannes Gutenberg University Mainz